While the majority of patients with obesity did not benefit from this treatment, patients with reduced basal leptin levels showed an improved reduction in fat mass (12) or body weight under treatment with Metreleptin (13). This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.